期刊文献+

门诊抑郁症患者的用药分析

下载PDF
导出
摘要 目的:分析门诊治疗抑郁症患者的用药情况。方法:抽取门诊开具的抗抑郁症用药处方2 160张,对其进行统计分析。结果:所有处方可分为6大类,合计14个药种,其中SSRI(选择性5-TH再摄取抑制剂)使用率最高,达38.7%;各种抗抑郁药物的剂量都控制在该药物说明书的推荐范围内;88.2%采用单一抗抑郁药,11.8%两药联合,无多药(三种及以上)联用现象。结论:目前临床上,药物治疗抑郁症已普遍采用新型抗抑郁药-SSRI,用药原则为尽量单一用药,需要二药联用时,谨慎选择,重视用药安全。
作者 郁婷婷
出处 《中国民康医学》 2014年第11期38-39,共2页 Medical Journal of Chinese People’s Health
  • 相关文献

参考文献4

二级参考文献28

  • 1方媛,刘鸣,张世洪.5-羟色胺综合征的发病机制、诊断和治疗[J].中华神经科杂志,2006,39(4):278-280. 被引量:14
  • 2刘伟.新型抗抑郁药物治疗抑郁症的用药选择[J].实用医技杂志,2007,14(11):1427-1428. 被引量:5
  • 3Keller MB,Lavori PW,Mueller TI,et al.Time to recovery chronicity,and levels of psychopathology in major depression:a 5-year prospective follow-up of 431 subjects[J].Arch Gen Psychiatry,1992,49(10):809-816.
  • 4Prien RF,Carpenter LL,Kupfer DJ.The definition and operational criteria for treatment outcome of major depressive disorder[J].Arch Gen Psychiatry,1991,48(9):796-800.
  • 5Frank E,Prien RF,Jarrett RB,et al.Conceptualization and rationale for consensus definition of terms in major depressive disorder[J].Arch Gen Psychiatry,1991,48(9):851-855.
  • 6Nierenberg AA,Wright EC.Evolution of remission as the new standard in the treatment of depression[J].J Clin Psychiatry,1999,60(suppl 22):7-11.
  • 7Judd LL,Akiskal HS,Maser JD,et al.Major depressive disorder:a prospective study of residual subthreshold depressive symptoms as a predictor of rapid relapse[J].J Affect Disord,1998,50(2/3):97-108.
  • 8Judd LL,Paulus MJ,Schettler PJ,et al.Does incomplete recovery from first lifetime major depressive disorder herald a chronic course of illness[J].Am J Psychiatry,2000,157(9):1501-1504.
  • 9Thase ME,Entsuah AR,Rudolph RL.Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors[J].Br J Psychiatry,2001,178:234-241.
  • 10Nemeroff CB,Entsuah R,Benattia I,et al.Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs[J].Biol Psychiatry,2008,63(4):424-434.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部